Major Companies in the Taiwan Autoimmune Disease Market | Insights & Key Players 2026

Taiwan Autoimmune Disease Market Overview

According to 6Wresearch, the Taiwan autoimmune disease market is set to witness stable growth, accelerated by a growing demand from the patient population and the expansion of private healthcare facilities offering specialized infusions. The market is expanding due to a surge in medical interventions, especially in the rheumatology and gastroenterology sectors involving the treatment of rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Additionally, this is a major segment for a number of companies that specialize in monoclonal antibodies and their biosimilar alternatives.

Competitive Landscape

The competitive landscape of the Taiwan autoimmune disease industry is formed by renowned giants and local distributors striving for a large market share in the immunology and specialized pharmacy sectors. Simultaneously, companies are focused on quality control, innovation of cytokine-targeting therapies, and adhering to global safety requirements.

Below is a list of leading players operating in the Taiwan Autoimmune Disease Market:

1. AbbVie Taiwan

AbbVie is a global leader in immunology, famously known for its pioneering treatments in rheumatoid arthritis, and Crohn's disease.

2. Roche Taiwan

Roche focuses on advanced biologics and targeted therapies for autoimmune conditions, particularly in rheumatology and personalized healthcare.

3. Novartis Taiwan

Novartis offers a broad portfolio of immunology treatments focusing on dermatological and musculoskeletal autoimmune disorders like plaque psoriasis.

4. Pfizer Taiwan

Pfizer provides various innovative small-molecule and biological treatments for chronic inflammatory and autoimmune conditions.

5. Johnson & Johnson (Innovative Medicine)

J&J is a dominant player in the immunology space, focusing on cytokines like IL-12/23 for treating psoriasis and IBD.

6. Sanofi Taiwan

Sanofi specializes in specialty care and immunology, specifically targeting Type 2 inflammatory diseases and severe skin conditions.

7. Eli Lilly Taiwan

Eli Lilly provides breakthrough therapies in the immunology sector, particularly for rheumatoid arthritis and autoimmune skin diseases.

8. Bristol Myers Squibb (Taiwan)

BMS is a significant contributor to the autoimmune market with a focus on biologics that modulate the immune system.

9. Amgen Taiwan

Amgen is a biotechnology pioneer, offering high-efficiency biological therapies and biosimilars for autoimmune and bone-related diseases.

10. Teva Pharmaceuticals (Taiwan)

Teva specializes in both innovative treatments and cost-effective biosimilars, increasing patient access to autoimmune therapies across Taiwan.